GNOM250117C15000
- 0.05
- 0.000.00%
Global X Fds Genomics & Biotechnology Etf Newsroom
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
Natera Shares Are Trading Higher After Canaccord Genuity Raised Its Price Target on the Stock From $165 to $180.
Natera Analyst Ratings
Santa Claus Came Without Rallying the Troops | Live Stock
Oracle, Snowflake Next up Among Top AI Software Plays in 2025: Wedbush
Top U.S. Health Care Mid-cap Stocks and Their Quant Ratings
Why Did Pfizer's Exit From the Gene Therapy Program Hit Sangamo Hard?
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
Weekly Buzz: So far, Santa is Letting us Down
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
4 Stocks to Watch on Friday: NFLX, AAPL on $4T Watch and More
How Is The Market Feeling About Illumina?
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
2024's 'Biggest Loses' That Could See Reversal in 2025
Sarepta Awarded $115.2M in Vyondys 53 Patent Case: Report
Traders Fight The Grinch To Save The Santa Rally: 10 S&P 500 Stocks Poised For A Year-End Surge
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings